This inventor holds 4 USPTO granted patents. Top assignee: Meiji Seika Kaisha, Ltd.. Active years: 2002-2006.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2002-2006
Title: Shigeki Suzuki: Innovator in Pharmaceutical Chemistry
Introduction
Shigeki Suzuki is a prominent inventor based in Yokohama, Japan. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that target lipid metabolism.
Latest Patents
Suzuki holds four patents, with his latest focusing on nitrogen-containing heterocyclic compounds and benzamide compounds. These compounds exhibit triglyceride biosynthesis inhibitory activity in the liver and inhibit the secretion of apolipoprotein B-containing lipoprotein. They are particularly noted for their effectiveness in treating and preventing hyperlipidemia and arteriosclerotic diseases, while minimizing side effects related to lipid accumulation in the liver.
Career Highlights
Shigeki Suzuki has established himself as a key figure in his field through his innovative research and development efforts. His work has led to advancements in drug formulations that are crucial for managing lipid-related health issues.
Collaborations
He collaborates with notable colleagues, including Naoto Ohkura and Yukiko Hiraiwa, to further enhance the impact of his research.
Conclusion
Shigeki Suzuki's contributions to pharmaceutical chemistry exemplify the importance of innovation in addressing health challenges. His work continues to influence the development of effective treatments for metabolic disorders.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile